Zyon Ayni, Code Pharma founder and CEO, quoted in The Jerusalem Post about CODIVIR, a drug used to treat HIV with a direct antiviral effect on coronavirus. Ayni said that the goal is to finish the trial in three to six months and then apply for emergency use authorization.
Ayni said: “We saw complete elimination of the virus in 90% to 100% of cells in less than 24 hours. There were no significant side effects from the treatment itself. One hospital there started administering it to COVID-19 patients, too, and they got completely better – some in hours and some in days. The world is in need of an antiviral medication against COVID”.
